THE FIRST NATURAL SUPPLEMENT CLINICALLY PROVEN TO COMBAT THE SYMPTOMS OF COVID-19 THIS INFORMATION IS NOT INTENT TO THE END CONSUMER

Changing everything

As the struggle continues against the pandemic of our lifetime, healthcare systems across the globe are in need of support. ArtemiC™ is the first food supplement clinically proven to prevent COVID-19 symptoms from deteriorating.

 ArtemiC™ has unlimited potential as an everyday treatment that can be taken at home, as well as in a clinical setting. By preventing the cytokine storm effect from ravaging a patient’s body, ArtemiC™ promises to be a valuable weapon against not only COVID-19, but a wide range of the diseases that threaten human health.

 ArtemiC™ Rescue – Clinically tested to be effective in reducing the inflammation of cell tissue and prevent the incubated production of the cytokines that cause uncontrolled inflammation.

PURE AND NATURAL FORMULATION

CLINICALLY
TESTED

HIGHLY EFFECTIVE

FORMULATION >

HOW IT WORKS >

POWERED BY MYCELL™ >

CLINICALLY PROVEN >

FORMULATION

A ground-breaking new supplement has been clinically proven to protect against the worst symptoms of COVID-19, that make the virus so dangerous, by targeting the immune response. Highly effective with only a small dosage, Phase II clinical trials confirm that this all-natural formulation can prevent a patient’s condition from deteriorating.

Until now, every new COVID-19 infection has increased the odds that the healthcare system would become overwhelmed and patients would no longer be able to access the care they need. With the support of ArtemiC Rescue™, a pioneering supplement developed by MCG Pharmaceuticals and powered by Swiss PharmaCan’s patented MyCell™ technology, fewer people will see their symptoms become life-threatening.

ArtemiC is a revolutionary food supplement that brings together the powerful anti-viral properties of four natural ingredients. To bring the fight directly to the cells and ensure the body can properly utilize every drop of the formulation, it uses patented MyCell™ technology to boost bioavailability.

ArtemiC Rescue™

Water based emulsion, oromucosal spray
RESCUE  – Prevents the immune response that causes organ damage and lung complications from COVID19

ArtemiC Support

Water based emulsion, oral drops
SUPPORT IMMUNE SYSTEM – protects the cells from oxidative stress, reduces tiredness and fatigue.

Immunomodulatory

enhances the body’s immune response and prevents the onset of the sometimes-deadly cytokine storm effect

Prevents blood clotting

 

 

Anti-inflammatory

reduces inflammation, including from the cytokine storm effect

Regulates mitochondrial function

helping to reduce the after-effects seen in Long COVID-19

Anti-microbial

reduces inflammation, including from the cytokine storm effect

How it works

When the immune system overreacts to a virus, it CAN be more dangerous than the virus itself

Current research suggests that our own immune systems may be to cause for the severe illness some patients experience after being infected with COVID-19. Put simply, this is due to an overreaction that causes more problems than the disease itself.

We have known since the SARS epidemic of 2003 that a significant number of deaths associated with viral infection can be traced to a phenomenon known as the cytokine storm. This occurs when replication of the virus inside the body leads to an excessive inflammatory response. Cytokines are biological chemicals that are used to stimulate cell pathways and communication between cells. Their main job is to signal the immune system to fight off an infection. Some cytokines make your blood clot more easily, for instance, while others help with antibody production.

However, a cytokine storm can occur when an excess of the chemicals responsible for controlling your inflammatory response are released, causing high levels of inflammation at their location in the body. This leads to a cascade effect that can be extremely dangerous and, in some cases, even fatal.

The cytokine storm effect is now thought to have been responsible for the disproportionate number of healthy young adults who died during the 1918 Spanish Flu epidemic, as well as deaths from the bird flu H5N1 and hantavirus pulmonary syndrome, among others. It is not a disease in itself, but a serious medical issue that can cause extreme damage, sometimes even leading to organ failure and death. ArtemiC was designed specifically to tackle this issue, helping your body fight the symptoms of the disease itself while blocking the overreaction that can cause the situation to quickly deteriorate.

Only Finest Natural Ingredients

Crafted from carefully selected plant parts of Curcuma Longa, Artemisia and Boswellia Serrata enhanced with Vitamin C

Four ingredients are brought together in an intelligent, highly effective formulation able to tackle the effects the COVID-19 virus can have on the human body.

  • Curcumin: Anti-viral activity comes from the inhibition of critical steps in viral replication, binding of the virus to the host cell and genome replication. Curcumin detects inflammation in the body and is a powerful anti-inflammatory agent, as well as creating antioxidant capacity.
  • Boswellia Serrata: Research has repeatedly demonstrated that the substances contained in the resin of frankincense have considerable potential as a treatment for diseases and viral infections. For example, Boswellia Serrata penetrates directly into the cells and kills the foreign invaders that cause infection.
  • Artemisia L.: Exhibits as anti-inflammatory, ,antioxidant, antispasmodic, antimicrobial, insecticidal, antimalarial, antifungal, and antioxidant activities
  • Vitamin C: Improves the body’s immune response and protects against foreign invaders.

powered by mycell™ technology

PURE BIOAVAILABILITY

 

Four active ingredients make ArtemiC an effective anti-viral treatment, but they share one major flaw: all have poor bioavailability when taken orally.

  • Bioavailability for vitamin C is less than 50% at higher doses, while oral administration even in high quantities cannot raise blood concentration above 0.22 mM.
  • Boswellia Serrata has low oral bioavailability because it is lipophilic in nature and insoluble in intestinal fluid.
  • Curcumin exhibits very poor bioavailability, with many studies showing low or even undetectable concentrations in the blood due to its poor absorption, rapid metabolism, chemical instability and rapid systemic elimination.

That’s where our award-winning, patented technology comes in. The MyCell™ delivery system increases the potency of the ingredients used in ArtemiC, boosting the supplement’s ability to assist the body in its fight against COVID-19 and other viral infections.

MyCell makes it possible to place a “skin” around oily substances that allows the active ingredients to be absorbed directly by the body’s cells. ArtemiC is thus in perfect harmony with the body, efficient and unique not only as a formulation, but also as a technology.  The encapsulated droplets target the cell and permeate the cell membrane for instant absorption, which leads to:

  • 100% water solubility
  • Protection of active ingredients against gastric fluids
  • Highest bioavailability
    • sub-lingual and intestinal absorption
    • no first-pass-effect liver
  • Highest and fastest bioactitivity (cellular absorption)

Clinically proven

In a phase II controlled clinical study designed to evaluate the effect of Artemic™ in patients diagnosed with COVID-19

ArtemiC was tested for safety and efficacy in a double-blind, placebo-controlled clinical trial involving 50 patients diagnosed with COVID-19. In Phase II clinical trials, ArtemiC statistically improved the recovery of patients infected with COVID-19. All patients had a confirmed COVID-19 infection, were hospitalized in a stable, moderate condition and were between the ages of 40 and 75.

By the end of the two-week trial, 100% of patients in the treatment group had shown improvement. Within 15 days of follow-up, all had fully recovered. No patients had required additional medical intervention and no adverse reactions to the treatment were recorded.

Those who were treated with ArtemiC showed:

  • Improved clinical recovery
  • Improvement of symptoms and pain
  • Faster overall recovery time
  • No requirement for additional medical assistance (ICU, ventilation).

All patients who were treated with ArtemiC met the required National Early Warning Score (NEWS) to be considered clinically recovered by the end of the study period. No patients had required additional medical intervention and no adverse reactions to the treatment were recorded.